---
title: "Gongdong Medical: Plans to invest 45.65 million yuan to acquire 55% equity in Jindongsheng"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/224541126.md"
description: "Gongdong Medical announced plans to invest CNY 45.65 million to acquire a 55% stake in Urumqi Jindongsheng Trading Co., Ltd., which will become a wholly-owned subsidiary. This investment does not involve related party transactions and has been approved by the board of directors. Jindongsheng's operating income for the year 2023 was CNY 66.4261 million, with a net profit of CNY 13.9091 million; for the period from January to September 2024, the operating income was CNY 45.3744 million, with a net profit of CNY 10.0646 million"
datetime: "2025-01-10T08:02:22.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/224541126.md)
  - [en](https://longbridge.com/en/news/224541126.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/224541126.md)
generator: "portal-rs"
---

# Gongdong Medical: Plans to invest 45.65 million yuan to acquire 55% equity in Jindongsheng

Gongdong Medical announced that the company plans to acquire 55% of the equity of Urumqi Jindongsheng Trading Co., Ltd. through equity transfer, with an investment amount of 45.65 million yuan, corresponding to a registered capital of 5.5 million yuan. This investment does not involve related party transactions and does not constitute a major asset restructuring. It has been approved by the board of directors and does not require submission to the shareholders' meeting for approval. After the investment is completed, Jindongsheng will become a wholly-owned subsidiary of the company. In 2023, Jindongsheng's operating income was 66.4261 million yuan, with a net profit of 13.9091 million yuan; from January to September 2024, the operating income was 45.3744 million yuan, with a net profit of 10.0646 million yuan

### Related Stocks

- [605369.CN](https://longbridge.com/en/quote/605369.CN.md)
- [00694.HK](https://longbridge.com/en/quote/00694.HK.md)
- [603326.CN](https://longbridge.com/en/quote/603326.CN.md)
- [01137.HK](https://longbridge.com/en/quote/01137.HK.md)

## Related News & Research

- [G Sachs: Central Capital Injection Into Insurance Sector Signals Support; Reiterates Buy Rating on PICC GROUP](https://longbridge.com/en/news/298263826.md)
- [Viromed Medical’s Heike Perbandt, closely associated with managing body member Uwe Perbandt, sells shares for EUR 52,000](https://longbridge.com/en/news/298227013.md)
- [Banca Popolare di Lajatico announces shareholder meeting](https://longbridge.com/en/news/298412632.md)
- [EWG: Double-digit revenue growth and digital platform adoption drive robust margins and returns](https://longbridge.com/en/news/298417346.md)
- [SynAct Pharma bolsters resomelagon data as it readies Phase 3 and weighs strategic deals](https://longbridge.com/en/news/298195637.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**